Collagen Solutions Plc (COS)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Collagen Solutions Plc (COS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011349
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Collagen Solutions Plc (Collagen Solutions), formerly Healthcare Investment Opportunities Plc is a medical device company that develops, manufactures and supplies medical grade collagen biomaterials and components. The company offers sourcing and supply of high grade collagen; provision of functional collagen bio-materials; and contract manufacture of collagen-based products and medical devices. It provides bovine spongiform encephalopathy (BSE)-free bovine biomaterials to meet customer specifications including bone, cartilage and tendon, and veins and blood vessels. Collagen Solutions’ products are used in research, diagnostics, medical devices and regenerative medicine. The company offers product development and contract manufacturing services including technology transfer and regulatory support to pharmaceutical and medical device companies. It has operations in the UK, the US, South Korea and New Zealand. Collagen Solutions is headquartered in Glasgow, the UK.

Collagen Solutions Plc (COS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Collagen Solutions Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Collagen Solutions Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Collagen Solutions Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Collagen Solutions Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Collagen Solutions Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Collagen Solutions Plc, Medical Equipment, Deal Details 11
Asset Purchase 11
Collagen Solutions Acquires ChondroMimetic from Orthomimetics and Cambridge Enterprise 11
Collagen Solutions (UK) Acquires Assets of Collagen Solutions 13
Venture Financing 14
Collbio Raises US$0.4 Million In Venture Financing 14
Partnerships 15
Collagen Solutions Enters into Development Agreement with Smart Matrix 15
Collagen Solutions Enters into Agreement with Electrospinning 16
Collagen Solutions Enters into Agreement with Kyeron Medical Innovations 17
Collagen Solutions Enters into Research Agreement with Jellagen 18
UCL Business Enters into Licensing Agreement with Collagen Solutions 19
Equity Offering 20
Collagen Solutions to Raise USD7.6 million in Private Placement of Shares 20
Collagen Solutions to Raise USD2.3 million in Rights Offering of Shares 22
Collagen Solutions Raises USD9.4 Million in Private Placement of Shares 24
Collagen Solutions Raises USD6 Million in Private Placement of Shares 25
Debt Offering 26
Collagen Solutions Raises USD2.5 Million in Private Placement of Bonds 26
Collagen Solutions to Raise USD1.3 Million in Private Placement of Bonds 27
Collagen Solutions to Raise USD1.25 Million in Private Placement of Bonds 28
Asset Transactions 29
Collagen Solutions (UK) Acquires Assets of Collagen Solutions 29
Acquisition 30
Collagen Solutions Acquires Southern Lights Biomaterials for USD9.4 Million 30
Healthcare Investment Acquires Collbio in Reverse Takeover Transaction 31
Collbio Acquires Angel Biomedical, Maker Of Biomedical Collagen Products, From Angel Biotechnology 32
Collagen Solutions Plc – Key Competitors 33
Collagen Solutions Plc – Key Employees 34
Collagen Solutions Plc – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Financial Announcements 36
Dec 05, 2017: Collagen Solutions: Interim Results for the six months ended 30 September 2017 36
Jul 11, 2017: Collagen Solutions: Final Results for the year ended 31 March 2017 37
Dec 19, 2016: Collagen Solutions Announces Interim Results for the six months ended 30 September 2016 38
Jul 11, 2016: Collagen Solutions Announces Final Results for the year ended 31 March 2016 39
May 03, 2016: Collagen Solutions Announces Preliminary FY 2016 Revenue 44
Corporate Communications 45
Dec 18, 2017: Collagen Solutions Strengthens Board with Non-Executive Appointment 45
Dec 14, 2017: Collagen Solutions: Appointment of Chief Financial Officer 46
Jan 19, 2017: Collagen Solutions Team Strengthened with New Scientific Advisory Board Appointments 47
May 04, 2016: Collagen Solutions Appoints Jamal Rushdy as Chief Executive Officer 48
May 03, 2016: Collagen Solutions Announces Leadership Changes 49
Product News 50
Jun 13, 2017: Collagen Solutions announces Provisional patent for Bone Graft Substitute formulation submitted 50
Other Significant Developments 51
Oct 26, 2017: Collagen Solutions: Trading Update and Notice of Results 51
Jul 25, 2017: Collagen Solutions: Transitioning to accelerated sustainable growth 52
Apr 24, 2017: Collagen Solutions: Consolidation of US R&D activities and Board change 58
Mar 20, 2017: Collagen Solutions introduces new online sales initiative in the US 59
Apr 19, 2016: Collagen Solutions Supplies Collagen Materials to Merck 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Collagen Solutions Plc, Medical Equipment, Key Facts, 2017 2
Collagen Solutions Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Collagen Solutions Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Collagen Solutions Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Collagen Solutions Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Collagen Solutions Plc, Deals By Market, 2011 to YTD 2017 9
Collagen Solutions Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Collagen Solutions Acquires ChondroMimetic from Orthomimetics and Cambridge Enterprise 11
Collagen Solutions (UK) Acquires Assets of Collagen Solutions 13
Collbio Raises US$0.4 Million In Venture Financing 14
Collagen Solutions Enters into Development Agreement with Smart Matrix 15
Collagen Solutions Enters into Agreement with Electrospinning 16
Collagen Solutions Enters into Agreement with Kyeron Medical Innovations 17
Collagen Solutions Enters into Research Agreement with Jellagen 18
UCL Business Enters into Licensing Agreement with Collagen Solutions 19
Collagen Solutions to Raise USD7.6 million in Private Placement of Shares 20
Collagen Solutions to Raise USD2.3 million in Rights Offering of Shares 22
Collagen Solutions Raises USD9.4 Million in Private Placement of Shares 24
Collagen Solutions Raises USD6 Million in Private Placement of Shares 25
Collagen Solutions Raises USD2.5 Million in Private Placement of Bonds 26
Collagen Solutions to Raise USD1.3 Million in Private Placement of Bonds 27
Collagen Solutions to Raise USD1.25 Million in Private Placement of Bonds 28
Collagen Solutions (UK) Acquires Assets of Collagen Solutions 29
Collagen Solutions Acquires Southern Lights Biomaterials for USD9.4 Million 30
Healthcare Investment Acquires Collbio in Reverse Takeover Transaction 31
Collbio Acquires Angel Biomedical, Maker Of Biomedical Collagen Products, From Angel Biotechnology 32
Collagen Solutions Plc, Key Competitors 33
Collagen Solutions Plc, Key Employees 34
Collagen Solutions Plc, Other Locations 35
Collagen Solutions Plc, Subsidiaries 35

★海外企業調査レポート[Collagen Solutions Plc (COS)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LI-COR Inc-製薬・医療分野:企業M&A・提携分析
    Summary LI-COR Inc (LCB), doing business as LI-COR Biosciences is a medical device company that offers research services. The company offers scientific instruments for plant science research. It designs, manufactures and markets instruments, software, reagents, and integrated systems for biotechnolo …
  • Cajun Industries, LLC:企業の戦略的SWOT分析
    Cajun Industries, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析
    AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PEN, Inc. (PENC):企業の財務・戦略的SWOT分析
    PEN, Inc. (PENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Akonni Biosystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company provides product such as nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray reader …
  • Quadra – Power Generation (TGKD):電力:M&Aディール及び事業提携情報
    Summary Quadra - Power Generation (Quadra) is an electric utility. It generates electricity and sells that on wholesale basis and in capacity market; and produces, transports, and sells thermal energy on retail market. The company has production facilities in Lipetsk, Voronezh, Tambov, Kursk, Belgor …
  • Equinox Energy Capital Ltd:電力:M&Aディール及び事業提携情報
    Summary Equinox Energy Capital Ltd (Equinox) is an investment management firm that invests in wind and renewable energy assets. The firm spans its expertise in permitting, construction and asset management. It acquires PV plants which have existing project finance, lease or mortgage financing. Equin …
  • Pinnacle West Capital Corporation:企業の戦略・SWOT・財務分析
    Pinnacle West Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary Pinnacle West Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Eindec Corporation Ltd (42Z):企業の財務・戦略的SWOT分析
    Eindec Corporation Ltd (42Z) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Linamar Corporation (LNR):企業の財務・戦略的SWOT分析
    Linamar Corporation (LNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Secure Trust Bank Plc:企業の戦略・SWOT・財務情報
    Secure Trust Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Secure Trust Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Banco Santander (Brasil) SA:企業のM&A・事業提携・投資動向
    Banco Santander (Brasil) SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Santander (Brasil) SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Advance Auto Parts, Inc.:企業の戦略・SWOT・財務分析
    Advance Auto Parts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Advance Auto Parts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ThromboGenics NV (THR)-製薬・医療分野:企業M&A・提携分析
    Summary ThromboGenics NV (ThromboGenics) is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreomacular adhesion (VMA) …
  • Oceaneering International Inc (OII):企業の財務・戦略的SWOT分析
    Oceaneering International Inc (OII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Inivata Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Inivata Ltd (Inivata) is a cancer genomics company that harnesses liquid biopsy platform to enhance personalized healthcare in oncology. The company’s product portfolio includes InVisionFirst – Lung, which offers advanced sequencing technology to detect copy number variants, single nucleotid …
  • NPC Co., Ltd.:企業の戦略・SWOT・財務情報
    NPC Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary NPC Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • C.A. Curtze Co. Inc.
    C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Orsted AS:発電所・企業SWOT分析
    Orsted AS - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • Acxiom Corporation:企業の戦略・SWOT・財務情報
    Acxiom Corporation - Strategy, SWOT and Corporate Finance Report Summary Acxiom Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆